Synergism between smoking and vital exhaustion in the risk of ischemic stroke: Evidence from the ARIC study

Annals of Epidemiology

Volumn 14, Issue 6, 2004, Pages 416-424

  Schwartz, Skai W ^a   Carlucci, Cheryl ^b   Chambless, Lloyd E ^c   Rosamond, Wayne D ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c IL   (United States)

Author keywords

ARIC; Atherosclerosis Risk in Communities; C reactive protein; cardiovascular disease; Cerebrovascular Accident; CI; Cohort Studies; confidence interval; CRP; CVD; Effect Modifiers (Epidemiology); hazard ratio; HR; IWT; Psychosomatic Medicine; Smoking

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; EXHAUSTION; FATIGUE; FEMALE; FOLLOW UP; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; SELF EVALUATION; SMOKING; SYMPTOM; VALIDATION PROCESS; VITAL EXHAUSTION;

AGED; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; EFFECT MODIFIERS (EPIDEMIOLOGY); FATIGUE; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROBABILITY; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SMOKING; UNITED STATES;

EID: 3142663971     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2003.10.010     Document Type: Article

References (60)

1. American Heart Association (AHA). Heart and Stroke Facts: 1997 Statistical Supplement. 1998;AHA, Dallas, TX
2. Broderick J., Brott T., Kothari R., Miller R., Khoury J., Panicoli A., et al. The greater Cincinnati/Northern Kentucky Stroke Study: Preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 29:1998;415-421
3. Taylor T.N., Davis P.H., Torner J.C., Holmes J., Meyer J.W., Jacobson M.F. Lifetime cost of stroke in the United States. Stroke. 27:1996;1459-1466
4. Hankey G.J. Smoking and risk of stroke. J Cardiovasc Risk. 6:(4):1999;207-211
5. Ockene I.S., Miller N.H. Cigarette smoking, cardiovascular disease, and stroke: A statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation. 96:(9):1997;3243-3247
6. Shinton R. Lifelong exposures and the potential for stroke prevention: The contribution of cigarette smoking, exercise, and body fat. J Epidemiol Community Health. 51:(2):1997;138-143
7. May M., McCarron P., Stansfeld S., Ben-Shlomo Y., Gallacher J., Yarnell J., et al. Does psychological distress predict the risk of ischemic stroke and transient ischemic attack? The Caerphilly Study. Stroke. 33:(1):2002;7-12
8. Simons L.A., McCallum J., Friedlander Y., Simons J. Risk factors for ischemic stroke: Dubbo study of the elderly. Stroke. 29:1998;1341-1346
9. Everson S.A., Roberts R.E., Goldenberg D.E., Kaplan G.A. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med. 158:1998;1133-1138
10. Simonsick E.M., Wallace R.B., Blazer D.G., Berkman L.F. Depressive symptomatology and hypertension-associated morbidity and mortality in older adults. Psychosom Med. 57:(5):1995;427-435
11. Jonas B.S., Mussolino M.A. Symptoms of depression as a prospective risk factor for stroke. Psychosom Med. 62:2000;463-471
12. Pomerleau O.F., Pomerleau C.S. Stress, smoking, and the cardiovascular system. J Subst Abuse. 1:(3):1989;331-343
13. Van Tiel E., Peeters P.H., Smit H.A., Nagelkerke N.J., Van Loon A.J., Grobbee D.E., et al. Quitting smoking may restore hematological characteristics within five years. Ann Epidemiol. 12:(6):2002;378-388
14. Mazzone A., Cusa C., Mazzucchelli I., Vezzoli M., Ottini E., Ghio S., et al. Cigarette smoking and hypertension influence nitric oxide release and plasma levels of adhesion molecules. Clin Chem Lab Med. 39:(9):2001;822-826
15. Elkind M.S., Cheng J., Boden-Albala B., Rundek T., Thomas J., Chen H., et al. Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke. 33:(1):2002;31-37
16. Hak A.E., Stehouwer C.D., Bots M.L., Polderman K.H., Schalkwijk C.G., Westendorp I.C., et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol. 19:(8):1999;1986-1991
17. Kiecolt-Glaser J.K., McGuire L., Robles T.F., Glaser R. Psychoneuroimmunology and psychosomatic medicine: Back to the future. Psychosom Med. 64:(1):2002;15-28
18. Lutgendorf S.K., Garand L., Buckwalter K.C., Reimer T.T., Hong S.Y., Lubaroff D.M. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol A Biol Sci Med Sci. 54:(9):1999;M434-M439
19. Gussekloo J., Schaap M.C., Frolich M., Blauw G.J., Westendorp R.G. C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons. Arterioscler Thromb Vasc Biol. 20:(4):2000;1047-1051
20. Folsom A.R., Rosamond W.D., Shahar E., Cooper L.S., Aleksic N., Nieto F.J., et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation. 100:1999;736-742
21. Kop W.J., Hamulyak K., Pernot C., Appels A. Relationship of blood coagulation and fibrinolysis to vital exhaustion. Psychosom Med. 60:(3):1998;352-358
22. van Diest R., Hamulyak K., Kop W.J., van Zandvoort C., Appels A. Diurnal variations in coagulation and fibrinolysis in vital exhaustion. Psychosom Med. 64:(5):2002;787-792
23. Perkins K.A., Epstein L.H., Jennings J.R., Stiller R. The cardiovascular effects of nicotine during stress. Psychopharmacologia. 90:(3):1986;373-378
24. Dembroski T.M., MacDougall J.M., Cardozo S.R., Ireland S.K., Krug-Fite J. Selective cardiovascular effects of stress and cigarette smoking in young women. Health Psychol. 4:(2):1985;153-167
25. Davis M.C. Oral contraceptive use and hemodynamic, lipid, and fibrinogen responses to smoking and stress in women. Health Psychol. 18:(2):1999;122-130
26. McGovern P.G., Shahar E., Folsom A.R., Rosamond W.D. No relation between excess fatigue and asymptomatic carotid atherosclerosis. Epidemiology. 7:1996;638-640
27. Kiechl S., Werner P., Egger G., Oberhollenzer F., Mayr M., Xu Q., et al. Active and passive smoking, chronic infections, and the risk of carotid atherosclerosis: Prospective results from the Bruneck Study. Stroke. 33:(9):2002;2170-2176
28. Appels A., Bar F.W., Bar J., Bruggeman C., de Baets M. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med. 62:(5):2000;601-605
29. Appels A., Höppener P., Mulder P. A questionnaire to assess premonitory symptoms of myocardial infarction. Int J Cardiol. 17:1987;15-24
30. Kop W.J., Appels A.P., Mendes de Leon C.F., de Swart H.B., Bar F.W. Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med. 56:(4):1994;281-287
31. Appels A., Mulder P. Fatigue and heart disease: The association between vital exhaustion and past, present, and future coronary heart disease. J Psychosom Res. 33:(6):1989;727-738
32. Appels A., Kop W.J., Schouten E. The nature of the depressive symptomatology preceding myocardial infarction. Behav Med. 26:(2):2000;86-89
33. Wojciechowski F.L., Strik J.J., Falger P., Lousberg R., Honig A. The relationship between depressive and vital exhaustion symptomatology post-myocardial infarction. Acta Psychiatr Scand. 102:(5):2000;359-365
34. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. Am J Epidemiol. 129:1989;687-702
35. Rosamond W.D., Folsom A.R., Chambless L.E., Wang C.H., McGovern P.G., Howard G., et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the atherosclerosis risk in communities (ARIC) Cohort. Stroke. 30:1999;736-743
36. Last J.M. A Dictionary of Epidemiology. 1983;Oxford University Press, New York/Oxford/Toronto
37. Eysenck H.J., Grossarth-Maticek R., Everitt B. Personality, stress, smoking, and genetic predisposition as synergistic risk factors for cancer and coronary heart disease. Integr Physiol Behav Sci. 26:(4):1991;309-322
38. Rothman K.J. Modern Epidemiology. 1st ed :1986;Little, Brown, and Company, Boston/Toronto. 317-325
39. Rice J.A. Mathematical Statistics and Data Analysis. 2nd ed :1995;Duxbury Press, Belmont, CA. 149-154
40. Assmann S.F., Hosmer D.W., Lemeshow S., Mundt K.A. Confidence intervals for measures of interaction. Epidemiology. 7:(3):1996;286-290
41. Panagiotakos D.B., Pitsavos C., Chrysohoou C., Moraiti A.D., Stefanadis C.I., Toutouzas P.K. The effect of short-term depressive episodes on the risk stratification of acute coronary syndromes: A case-control study in Greece (Cardio 2000). Acta Cardiol. 56:(6):2001;357-365
42. Pollini G., Maugeri U., Bernardo A., Jedrychowski W., Flak E. The joint effect of overweight and familial predisposing factors on the occurrence of hypertension in the industrial population. The Pavia study. Giornale Italiano di Medicina del Lavoro. 9:(3-4):1987;163-171
43. Nomura Y., Warner V., Wickramaratne P. Parents concordant for major depressive disorder and the effect of psychopathology in offspring. Psychol Med. 31:(7):2001;1211-1222
44. Reiner A.P., Schwartz S.M., Kumar P.N., Rosendaal F.R., Pearce R.M., Aramaki K.M., et al. Platelet glycoprotein IIb polymorphism, traditional risk factors and non-fatal myocardial infarction in young women. Br J Haematol. 112:(3):2001;632-636
45. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress, and coronary heart disease: Is interleukin-6 the link? Atherosclerosis. 148:(2):1999;209-214
46. McCarty M.F. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: Down-regulation with essential fatty acids, ethanol, and pentoxifylline. Med Hypotheses. 52:(5):1999;465-477
47. Lutgendorf S.K., Garand L., Buckwalter K.C., Reimer T.T., Hong S.Y., Lubaroff D.M. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol A Biol Sci Med Sci. 54:(9):1999;M434-M439
48. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Kales A., Tyson K., Chrousos G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity. J Clin Endocrinol Metab. 82:(5):1997;1313-1316
49. Margaglione M., Bossone A., Cappucci G., Colaizzo D., Grandone E., Di Minno G. The effect of the interleukin-6 c/g-174 polymorphism and circulating interleukin-6 on fibrinogen plasma levels. Haematologica. 86:(2):2001;199-204
50. Bataille R., Klein B. C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo. Arthritis Rheum. 35:1992;982-983
51. Vickers M.A., Green F.R., Terry C., Mayosi B.M., Julier C., Lathrop M., Ratcliffe P.J., Watkins H.C., Keavney B. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res. 53:(4):2002;1029-1034
52. Danesti J., Collins R., Appleby P., Peto R. Association of fibrinogen, C-reactive protein, albumin or leukocyte count with coronary heart disease: Meta-analysis of prospective studies. JAMA. 279:1998;1477-1482
53. Ridker P.M., Buring J.E., Shih J., Matias M., Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 98:1998;731-733
54. Ford E.S., Giles W.H. Serum C-reactive protein and self-reported stroke: Findings from the Third National Health and Nutrition Examination Survey. Arterioscler Thromb Vasc Biol. 20:(4):2000;1052-1056
55. Gussekloo J., Schaap M.C.L., Frölich M., Blauw G.J., Westendorp R.G.J. C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons. Arterioscler Thromb Vasc Biol. 20:(4):2000;1047-1051
56. Vila N., Reverter J.C., Yague J., Chamorro A. Interaction between interleukin-6 and the natural anticoagulant system in acute stroke. J Interferon Cytokine Res. 20:(3):2000;325-329
57. Beamer N.B., Coull B.M., Clark W.M., Hazel J.S., Silberger J.R. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol. 37:(6):1995;800-805
58. Powell J.T. Vascular damage from smoking: Disease mechanisms at the arterial wall. Vasc Med. 3:(1):1998;21-28
59. Tracy R.P., Psaty B.M., Macy E., Bovill E.G., Cushman M., Cornell E.S., et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 17:(10):1997;2167-2176
60. Howard G., Wagenknecht L.E., Burke G.L., Diez-Roux A., Evans G.W., McGovern P., et al., for the ARIC investigators. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA. 279:(2):1998;119-124